SG Americas Securities, LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753U906. A total of 8 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2
-99.9%
13,500
-95.5%
0.00%
-100.0%
Q1 2023$2,190300,0000.02%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
PICTON MAHONEY ASSET MANAGEMENT 122,500$4,6610.14%
GROUP ONE TRADING, L.P. 944,400$35,924,9760.12%
SIMPLEX TRADING, LLC 519,200$19,7500.02%
JANE STREET GROUP, LLC 879,500$33,456,1800.01%
IMC-Chicago, LLC 50,500$1,921,0200.00%
JPMORGAN CHASE & CO 556,300$21,161,6520.00%
SG Americas Securities, LLC 13,500$20.00%
Twin Tree Management, LP 100$3,8040.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of APELLIS PHARMACEUTICALS INC shareholders